cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Jazz Pharmaceuticals Plc
20 own
19 watching
Current Price
$155.64
$-0.76
(-0.49%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
9,788.2M
52-Week High
52-Week High
169.98
52-Week Low
52-Week Low
125.36
Average Volume
Average Volume
0.4M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
199.9066
iconMarket Capitalization9,788.2M
icon52-Week High169.98
icon52-Week Low125.36
iconAverage Volume0.4M
iconDividend Yield--
iconP/E Ratio199.9066
What does the Jazz Pharmaceuticals Plc do?
Jazz Pharmaceuticals Public Limited Company, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. It markets Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in patients with narcolepsy; Erwinaze to treat acute lymphoblastic leukemia (ALL); Defitelio for the treatment and prevention of severe hepatic veno-occlusive disease, a potentially life-threatening complication of hematopoietic stem cell transplantation; and Prialt, an intrathecally administered infusion of ziconotide for the management of severe chronic pain. The company also develops JZP-110, which is in phase III clinical trial for the treatment of excessive sleepiness (ES) in patients with narcolepsy and obstructive sleep apnea, as well as phase II clinical trial for ES associated with Parkinson's disease; Vyxeos (CPX-351) for high-risk acute myeloid leukemia; and JZP-507 and JZP-258 to treat EDS and cataplexy in narcolepsy, as well as evaluates deuterated oxybate for narcolepsy. In addition, it sells psychiatry and other products. The company is headquartered in Dublin, Ireland.
Read More
How much money does Jazz Pharmaceuticals Plc make?
News & Events about Jazz Pharmaceuticals Plc.
PR Newswire
17days ago
Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evaluating Zanidatamab in HER2-Expressing Metastatic Gastroesophageal Adenocarcinoma Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evaluating...
PR Newswire
1month ago
Jazz Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference Jazz Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference PR Newswire DUBLIN, Jan. 3, 2023 DUBLIN, Jan. 3, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced...
Insider Monkey
1month ago
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2022 Earnings Call Transcript November 9, 2022 Jazz Pharmaceuticals plc beats earnings expectations. Reported EPS is $5.17, expectations were $4.66. Operator: Good day, and thank you for standing by. Welcome to the Q3 2022 Jazz Pharmaceuticals Earnings Call...
GeekWire
1month ago
Zymeworks will receive $350 million from Jazz Pharmaceuticals in return for the right to develop and commercialize Zymeworks lead drug candidate, zanidatamab, in the U.S., Europe and Japan. The new cash builds on a $50 million payment earlier this year and comes after Tuesdays release of positive ...
PR Newswire
1month ago
Jazz Pharmaceuticals and Zymeworks Announce Jazz has Confirmed Opt-in and Advances Partnership for Zanidatamab Jazz Pharmaceuticals and Zymeworks Announce Jazz has Confirmed Opt-in and Advances Partnership for Zanidatamab PR Newswire DUBLIN and VANCOUVER, BC, Dec. 21, 2022 Follows positive top-line...
Frequently Asked Questions
Frequently Asked Questions
What is Jazz Pharmaceuticals Plc share price today?
plus_minus_icon
Can Indians buy Jazz Pharmaceuticals Plc shares?
plus_minus_icon
How can I buy Jazz Pharmaceuticals Plc shares from India?
plus_minus_icon
Can Fractional shares of Jazz Pharmaceuticals Plc be purchased?
plus_minus_icon
What are the documents required to start investing in Jazz Pharmaceuticals Plc stocks?
plus_minus_icon
What is today’s traded volume of Jazz Pharmaceuticals Plc?
plus_minus_icon
What is today’s market capitalisation of Jazz Pharmaceuticals Plc?
plus_minus_icon
What is the 52-Week High and Low Range of Jazz Pharmaceuticals Plc?
plus_minus_icon
What percentage is Jazz Pharmaceuticals Plc down from its 52-Week High?
plus_minus_icon
What percentage is Jazz Pharmaceuticals Plc up from its 52-Week Low?
plus_minus_icon
Current Price
$155.64
$-0.76
(-0.49%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00